Long-Term Phosphodiesterase 5 Inhibitor Use Is Safe and Improves Symptoms in Patients with Pre-Capillary Pulmonary Hypertension of Sickle Cell Disease

被引：0
|
作者：
Cramer-Bour, C. [1 ]
Ruopp, N. [2 ]
Emeh, R. [3 ]
Ruhl, A. [4 ]
Weir, N. A. [5 ]
Thein, S. [4 ]
Nouraie, S. [6 ]
Klings, E. S. [7 ]
机构：
[1] Boston Univ, Pulm, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Pulm Crit Care, 75 Francis St, Boston, MA 02115 USA
[3] Howard Univ, Washington, DC 20059 USA
[4] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[5] Fed Drug Adm, Rockville, MD USA
[6] Univ Pittsburgh, Med, PACCM, Pittsburgh, PA USA
[7] Boston Univ, Sch Med, Pulm Ctr Houseman R304, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7218
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension
    Kramer, Tilmann
    Dumitrescu, Daniel
    Gerhardt, Felix
    Orlova, Kristina
    ten Freyhaus, Henrik
    Hellmich, Martin
    Baldus, Stephan
    Rosenkranz, Stephan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 283 : 152 - 158
  • [22] Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension
    Michelakis, ED
    Tymchak, W
    Noga, M
    Webster, L
    Wu, XC
    Lien, D
    Wang, SH
    Modry, D
    Archer, SL
    CIRCULATION, 2003, 108 (17) : 2066 - 2069
  • [23] An experience with long-term use of 5-mononitrate in patients with stable pulmonary hypertension
    Arutyunov, GP
    Korsunskaya, MI
    Chernyavskaya, TK
    Rosanov, AV
    Vershinin, AA
    KARDIOLOGIYA, 2001, 41 (01) : 48 - 54
  • [24] Long-term treatment with a phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart failure through enhancing the natriuretic peptides-cGMP pathway
    Yamamoto, T
    Wada, A
    Tsutamoto, T
    Ohnishi, M
    Horie, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (05) : 596 - 600
  • [25] Long-term treatment with phosphodiesterase type 5 inhibitor improves pulmonary hypertension caused by congestive heart failure through a natriuretic peptides-cGMP pathway
    Yamamoto, T
    Wada, A
    Ohnishi, M
    Tsutamoto, T
    Fujii, M
    Matsumoto, T
    Takayama, T
    Kinoshita, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 224A - 224A
  • [26] Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
    Nishimura, Masato
    Tokoro, Toshiko
    Yamazaki, Satoru
    Hashimoto, Tetsuya
    Kobayashi, Hiroyuki
    Ono, Toshihiko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (06) : 1088 - 1096
  • [27] Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
    Masato Nishimura
    Toshiko Tokoro
    Satoru Yamazaki
    Tetsuya Hashimoto
    Hiroyuki Kobayashi
    Toshihiko Ono
    Clinical and Experimental Nephrology, 2017, 21 : 1088 - 1096
  • [28] Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure
    Tsuchida, Kosei
    Yamada, Hidehiro
    Yamasaki, Yoshioki
    Suzuki, Kengo
    Kongoji, Ken
    Akashi, Yoshihiro
    Ozaki, Shoichi
    MODERN RHEUMATOLOGY, 2015, 25 (05) : 744 - 747
  • [29] Long-term bosentan improves the quality of life of patients with pulmonary arterial hypertension
    Frost, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 495A - 496A
  • [30] Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary Hypertension
    Miguel Perez-Penate, Gregorio
    Julia-Serda, Gabriel
    Ojeda-Betancort, Nazario
    Garcia-Quintana, Antonio
    Pulido-Duque, Juan
    Rodriguez-Perez, Aurelio
    Cabrera-Navarro, Pedro
    Angel Gomez-Sanchez, Miguel
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (12): : 1326 - 1332
12345